Pain Therapeutics, Inc. (PTIE): Price and Financial Metrics
PTIE Stock Price Chart More Charts
PTIE Price/Volume Stats
Pain Therapeutics, Inc. (PTIE) Company Bio
Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The companys lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimers disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.